Trilaciclib (G1T28)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Trilaciclib (G1T28), covering 2022-05-06 to 2022-05-06. Get the full timeline:
Most recent: Clinical Trial Update: Carboplatin, Etoposide, and Atezolizumab With or Without Trilaciclib (G1T28), a CDK4/6 Inhibitor, in Extensive-Stage SCLC [Phase 2]